THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Farther Finance Advisors, LLC's Holding History (CIK: 0001992825)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 53 Value ($000) $1 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 78 Value ($000) $1 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 23 Value ($000) $0 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 23 Value ($000) $0 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 23 Value ($000) $0 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 23 Value ($000) $0 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 23 Value ($000) $0 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 23 Value ($000) $0 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 27 Value ($000) $0 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 27 Value ($000) $0 Avg Close $9.65 Range $8.25 - $10.59